Slide background

Slide background
Slide background
Slide background

Loading Events
November
2019
21
Machine Learning in Population Genomics

5:00 PM — 8:00 PM

Moderated by Eimear Kenny, PhD, and Adam Siepel, PhD

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR

About

The NYGC has created a Population Genomics Group that brings together leading population and statistical geneticists and focuses on human population genomics, statistical analyses, and applications to precision medicine. The group is led by Eimear Kenny, PhD, of the Icahn School of Medicine at Mount Sinai, and Adam Siepel, PhD, of Cold Spring Harbor Laboratory.

 

WHEN:
Thursday, November 21, 2019
5:00 PM – 7:00 PM: Speaker Presentations and Q&A
7:00 PM – 8:00 PM: Wine & Cheese Networking

 

WHERE:
New York Genome Center
101 Avenue of the Americas, 1st Floor Auditorium

REGISTER

 

SPEAKERS

Peter Koo, PhD
Assistant Professor
Cold Spring Harbor Laboratory

 

“Uncovering Data-Driven Biological Insights With Deep Learning”

 

To learn more about Dr. Koo’s research, visit his lab page.

 

 

 

Smita Krishnaswamy, PhD
Assistant Professor of Genetics and of Computer Science
Yale School of Medicine

 

“Detecting Structure and Patterns in Big Biomedical Data”

 

To learn more about Dr. Krishnaswamy’s research, visit her lab page.

 

 

 

Christina Leslie, PhD
Associate Member, Computational Biology Program, Sloan Kettering Institute
Memorial Sloan Kettering Cancer Center

 

“Decoding Epigenomic Programs and Cell States”

 

To learn more about Dr. Leslie’s research, visit her lab page.

 

 

Discussion and Q&A
Discussion and Q&A will take place after each speaker presents.
Any questions on this event, contact events@nygenome.org.

 

  • EVENING TALKS
    The New York Genome Center’s Evening Talks events feature distinguished experts from around the world sharing genomic insights and research. They are intended to showcase and explain high science to the non-scientific community. Speakers present the latest research findings and explain its implication for helping improve clinical care for a wide array of serious diseases. The lecture is followed by a lively question-and-answer session and a post-event reception of hors d’oeuvres and cocktails. These popular free public events are held in the Center’s state-of-the-art ground-floor auditorium starting at 6:00 pm. The Evening Talks Series is sponsored by The New York Community Trust – Pyewacket Fund.

  • Workshops
  • Computational Cancer Genomics Working Group Evening Lectures
    Computational Cancer Genomics Working Group is led by Simon Tavaré, PhD, NYGC and Columbia University, and Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center. This group will build collaborations that apply novel statistical approaches and population-level analyses to major cohorts in cancer genomics.

  • Neurodegenerative Disease Working Group Evening Lectures
    The NYGC is leveraging the success of the Center for Genomics of Neurodegenerative Disease (CGND) to extend our work across a range of neurodegenerative diseases that have pathways in common with ALS, including Alzheimer’s, Parkinson’s and Huntington’s diseases. The NYGC has created a new Neurodegenerative Disease Working Group, led by Alison Goate, DPhil, Icahn School of Medicine at Mount Sinai, Hemali Phatnani, PhD, NYGC, and Phil De Jager, PhD, MD, MMSc, Columbia University Irving Medical Center, with the objective of bringing together researchers from NYGC’s institutional founding members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neurodegenerative disease.

  • Neuropsychiatric Disease Working Group Evening Lectures
    The NYGC has created a new scientific working group with the objective of bringing together researchers from our Institutional Founding Members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neuropsychiatric disease.